Annual Total Long Term Liabilities
$37.00 K
-$69.00 K-65.09%
December 31, 2023
Summary
- As of February 12, 2025, CYCC annual total long term liabilities is $37.00 thousand, with the most recent change of -$69.00 thousand (-65.09%) on December 31, 2023.
- During the last 3 years, CYCC annual total long term liabilities has fallen by -$1.02 million (-96.50%).
- CYCC annual total long term liabilities is now -99.95% below its all-time high of $68.63 million, reached on December 31, 2003.
Performance
CYCC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$5000.00-100.00%
September 30, 2024
Summary
- As of February 12, 2025, CYCC quarterly total long term liabilities is $0.00, with the most recent change of -$5000.00 (-100.00%) on September 30, 2024.
- Over the past year, CYCC quarterly long term liabilities has dropped by -$37.00 thousand (-100.00%).
- CYCC quarterly long term liabilities is now -100.00% below its all-time high of $68.63 million, reached on December 31, 2003.
Performance
CYCC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CYCC Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.1% | -100.0% |
| 3 y3 years | -96.5% | -100.0% |
| 5 y5 years | -63.0% | -100.0% |
CYCC Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.1% | +23.3% | -100.0% | at low |
| 5 y | 5-year | -96.9% | +23.3% | -100.0% | at low |
| alltime | all time | -100.0% | -100.0% | -100.0% | at low |
Cyclacel Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $5000.00(-76.2%) |
| Mar 2024 | - | $21.00 K(-43.2%) |
| Dec 2023 | $37.00 K(-65.1%) | $37.00 K(-28.8%) |
| Sep 2023 | - | $52.00 K(-21.2%) |
| Jun 2023 | - | $66.00 K(-17.5%) |
| Mar 2023 | - | $80.00 K(-24.5%) |
| Dec 2022 | $106.00 K(+253.3%) | $106.00 K(-0.9%) |
| Sep 2022 | - | $107.00 K(-5.3%) |
| Jun 2022 | - | $113.00 K(+653.3%) |
| Mar 2022 | - | $15.00 K(-50.0%) |
| Dec 2021 | $30.00 K(-97.2%) | $30.00 K(-31.8%) |
| Sep 2021 | - | $44.00 K(>+9900.0%) |
| Jun 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $996.00 K(-5.8%) |
| Dec 2020 | $1.06 M(-11.3%) | $1.06 M(-0.6%) |
| Sep 2020 | - | $1.06 M(-1.7%) |
| Jun 2020 | - | $1.08 M(+0.7%) |
| Mar 2020 | - | $1.07 M(-9.9%) |
| Dec 2019 | $1.19 M(+1091.0%) | $1.19 M(+3.2%) |
| Sep 2019 | - | $1.15 M(-6.4%) |
| Jun 2019 | - | $1.23 M(-16.0%) |
| Mar 2019 | - | $1.47 M(+1368.0%) |
| Dec 2018 | $100.00 K(-19.4%) | $100.00 K(-5.7%) |
| Sep 2018 | - | $106.00 K(-5.4%) |
| Jun 2018 | - | $112.00 K(-9.7%) |
| Mar 2018 | - | $124.00 K(0.0%) |
| Dec 2017 | $124.00 K(-4.6%) | $124.00 K(-3.1%) |
| Sep 2017 | - | $128.00 K(0.0%) |
| Jun 2017 | - | $128.00 K(+0.8%) |
| Mar 2017 | - | $127.00 K(-2.3%) |
| Dec 2016 | $130.00 K(-26.1%) | $130.00 K(-7.8%) |
| Sep 2016 | - | $141.00 K(-6.0%) |
| Jun 2016 | - | $150.00 K(-9.6%) |
| Mar 2016 | - | $166.00 K(-5.7%) |
| Dec 2015 | $176.00 K(-14.6%) | $176.00 K(-5.4%) |
| Sep 2015 | - | $186.00 K(-6.1%) |
| Jun 2015 | - | $198.00 K(+3.1%) |
| Mar 2015 | - | $192.00 K(-6.8%) |
| Dec 2014 | $206.00 K | $206.00 K(-6.8%) |
| Sep 2014 | - | $221.00 K(-7.1%) |
| Jun 2014 | - | $238.00 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $241.00 K(>+9900.0%) | $241.00 K(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2009 | - | $267.00 K(-49.2%) |
| Jun 2009 | - | $526.00 K(-62.9%) |
| Mar 2009 | - | $1.42 M(-16.1%) |
| Dec 2008 | $1.69 M(-47.8%) | $1.69 M(-14.6%) |
| Sep 2008 | - | $1.98 M(-9.9%) |
| Jun 2008 | - | $2.19 M(-26.9%) |
| Mar 2008 | - | $3.00 M(-7.1%) |
| Dec 2007 | $3.23 M(+125.0%) | $3.23 M(+235.2%) |
| Sep 2007 | - | $964.00 K(-8.8%) |
| Jun 2007 | - | $1.06 M(-85.9%) |
| Mar 2007 | - | $7.52 M(+423.7%) |
| Dec 2006 | $1.44 M(+1741.0%) | $1.44 M(-14.2%) |
| Sep 2006 | - | $1.67 M(+8.1%) |
| Jun 2006 | - | $1.55 M(-13.7%) |
| Mar 2006 | - | $1.79 M(+2198.7%) |
| Dec 2005 | $78.00 K(-98.1%) | $78.00 K(-97.8%) |
| Sep 2005 | - | $3.61 M(-11.7%) |
| Jun 2005 | - | $4.09 M(+4.2%) |
| Mar 2005 | - | $3.92 M(-3.6%) |
| Dec 2004 | $4.07 M(-94.1%) | $4.07 M(+15.2%) |
| Sep 2004 | - | $3.53 M(+36.2%) |
| Jun 2004 | - | $2.59 M(+50.3%) |
| Mar 2004 | - | $1.73 M(-97.5%) |
| Dec 2003 | $68.63 M | $68.63 M |
FAQ
- What is Cyclacel Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Cyclacel Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CYCC is $37.00 K
What is the all time high annual total long term liabilities for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual total long term liabilities is $68.63 M
What is Cyclacel Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CYCC annual total long term liabilities has changed by -$69.00 K (-65.09%)
What is Cyclacel Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CYCC is $0.00
What is the all time high quarterly long term liabilities for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly total long term liabilities is $68.63 M
What is Cyclacel Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CYCC quarterly total long term liabilities has changed by -$37.00 K (-100.00%)